APO Research
Talk to an analyst

APO RESEARCH · REPORT

Praziquantel

Compare research editions
View pricing & licenses

Selected research

Industry Research

Praziquantel Industry Research Report 2026

19 December 2025145 pages

Choose your research edition.

Industry ResearchPraziquantel Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Praziquantel Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Praziquantel Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Praziquantel Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Praziquantel Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Praziquantel market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Praziquantel is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Praziquantel is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Praziquantel is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Praziquantel include Zoetis, Merck, Bayer, Soparfin, Shin Poong Pharm, Richter Pharma, Norbrook Laboratories, Merial and Mavlab Animal Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Praziquantel market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Praziquantel Market by Company

Zoetis

Merck

Bayer

Soparfin

Shin Poong Pharm

Richter Pharma

Norbrook Laboratories

Merial

Mavlab Animal Health

Lavet Pharmaceuticals

Kyron Pharma

Krka

Ecuphar

Covetrus

CiplaVet

Chanelle Pharma

Ceva Santé Animale

C and H Generics

Auvex

AniMedica

Praziquantel Segment by Type

Patent

Generic

Praziquantel Segment by Application

Liver Fluke Infection

Cysticercosis

Cestode Infections

Trematode Infections

Schistosoma Infection

Others

Praziquantel Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Praziquantel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Praziquantel and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Praziquantel.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Praziquantel manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Praziquantel by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Praziquantel in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Praziquantel Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Praziquantel Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Praziquantel Sales Market Share by Manufacturers (2021-2026) Table 8. Global Praziquantel Revenue of Manufacturers (2021-2026) Table 9. Global Praziquantel Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Praziquantel Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Praziquantel Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Praziquantel, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Praziquantel, Product Type & Application Table 14. Global Praziquantel Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Praziquantel by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Zoetis Company Information Table 19. Zoetis Business Overview Table 20. Zoetis Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Zoetis Praziquantel Product Portfolio Table 22. Zoetis Recent Developments Table 23. Merck Company Information Table 24. Merck Business Overview Table 25. Merck Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Merck Praziquantel Product Portfolio Table 27. Merck Recent Developments Table 28. Bayer Company Information Table 29. Bayer Business Overview Table 30. Bayer Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Bayer Praziquantel Product Portfolio Table 32. Bayer Recent Developments Table 33. Soparfin Company Information Table 34. Soparfin Business Overview Table 35. Soparfin Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Soparfin Praziquantel Product Portfolio Table 37. Soparfin Recent Developments Table 38. Shin Poong Pharm Company Information Table 39. Shin Poong Pharm Business Overview Table 40. Shin Poong Pharm Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Shin Poong Pharm Praziquantel Product Portfolio Table 42. Shin Poong Pharm Recent Developments Table 43. Richter Pharma Company Information Table 44. Richter Pharma Business Overview Table 45. Richter Pharma Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Richter Pharma Praziquantel Product Portfolio Table 47. Richter Pharma Recent Developments Table 48. Norbrook Laboratories Company Information Table 49. Norbrook Laboratories Business Overview Table 50. Norbrook Laboratories Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Norbrook Laboratories Praziquantel Product Portfolio Table 52. Norbrook Laboratories Recent Developments Table 53. Merial Company Information Table 54. Merial Business Overview Table 55. Merial Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Merial Praziquantel Product Portfolio Table 57. Merial Recent Developments Table 58. Mavlab Animal Health Company Information Table 59. Mavlab Animal Health Business Overview Table 60. Mavlab Animal Health Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Mavlab Animal Health Praziquantel Product Portfolio Table 62. Mavlab Animal Health Recent Developments Table 63. Lavet Pharmaceuticals Company Information Table 64. Lavet Pharmaceuticals Business Overview Table 65. Lavet Pharmaceuticals Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Lavet Pharmaceuticals Praziquantel Product Portfolio Table 67. Lavet Pharmaceuticals Recent Developments Table 68. Kyron Pharma Company Information Table 69. Kyron Pharma Business Overview Table 70. Kyron Pharma Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Kyron Pharma Praziquantel Product Portfolio Table 72. Kyron Pharma Recent Developments Table 73. Krka Company Information Table 74. Krka Business Overview Table 75. Krka Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Krka Praziquantel Product Portfolio Table 77. Krka Recent Developments Table 78. Ecuphar Company Information Table 79. Ecuphar Business Overview Table 80. Ecuphar Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Ecuphar Praziquantel Product Portfolio Table 82. Ecuphar Recent Developments Table 83. Covetrus Company Information Table 84. Covetrus Business Overview Table 85. Covetrus Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Covetrus Praziquantel Product Portfolio Table 87. Covetrus Recent Developments Table 88. CiplaVet Company Information Table 89. CiplaVet Business Overview Table 90. CiplaVet Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. CiplaVet Praziquantel Product Portfolio Table 92. CiplaVet Recent Developments Table 93. Chanelle Pharma Company Information Table 94. Chanelle Pharma Business Overview Table 95. Chanelle Pharma Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Chanelle Pharma Praziquantel Product Portfolio Table 97. Chanelle Pharma Recent Developments Table 98. Ceva Santé Animale Company Information Table 99. Ceva Santé Animale Business Overview Table 100. Ceva Santé Animale Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Ceva Santé Animale Praziquantel Product Portfolio Table 102. Ceva Santé Animale Recent Developments Table 103. C and H Generics Company Information Table 104. C and H Generics Business Overview Table 105. C and H Generics Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. C and H Generics Praziquantel Product Portfolio Table 107. C and H Generics Recent Developments Table 108. Auvex Company Information Table 109. Auvex Business Overview Table 110. Auvex Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Auvex Praziquantel Product Portfolio Table 112. Auvex Recent Developments Table 113. AniMedica Company Information Table 114. AniMedica Business Overview Table 115. AniMedica Praziquantel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. AniMedica Praziquantel Product Portfolio Table 117. AniMedica Recent Developments Table 118. Global Praziquantel Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 119. Global Praziquantel Sales by Region (2021-2026) & (K Units) Table 120. Global Praziquantel Sales Market Share by Region (2021-2026) Table 121. Global Praziquantel Sales by Region (2027-2032) & (K Units) Table 122. Global Praziquantel Sales Market Share by Region (2027-2032) Table 123. Global Praziquantel Revenue by Region (2021-2026) & (US$ Million) Table 124. Global Praziquantel Revenue Market Share by Region (2021-2026) Table 125. Global Praziquantel Revenue by Region (2027-2032) & (US$ Million) Table 126. Global Praziquantel Revenue Market Share by Region (2027-2032) Table 127. North America Praziquantel Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. North America Praziquantel Sales by Country (2021-2026) & (K Units) Table 129. North America Praziquantel Sales by Country (2027-2032) & (K Units) Table 130. North America Praziquantel Revenue by Country (2021-2026) & (US$ Million) Table 131. North America Praziquantel Revenue by Country (2027-2032) & (US$ Million) Table 132. Europe Praziquantel Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Europe Praziquantel Sales by Country (2021-2026) & (K Units) Table 134. Europe Praziquantel Sales by Country (2027-2032) & (K Units) Table 135. Europe Praziquantel Revenue by Country (2021-2026) & (US$ Million) Table 136. Europe Praziquantel Revenue by Country (2027-2032) & (US$ Million) Table 137. Asia Pacific Praziquantel Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Asia Pacific Praziquantel Sales by Country (2021-2026) & (K Units) Table 139. Asia Pacific Praziquantel Sales by Country (2027-2032) & (K Units) Table 140. Asia Pacific Praziquantel Revenue by Country (2021-2026) & (US$ Million) Table 141. Asia Pacific Praziquantel Revenue by Country (2027-2032) & (US$ Million) Table 142. South America Praziquantel Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. South America Praziquantel Sales by Country (2021-2026) & (K Units) Table 144. South America Praziquantel Sales by Country (2027-2032) & (K Units) Table 145. South America Praziquantel Revenue by Country (2021-2026) & (US$ Million) Table 146. South America Praziquantel Revenue by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Praziquantel Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Middle East and Africa Praziquantel Sales by Country (2021-2026) & (K Units) Table 149. Middle East and Africa Praziquantel Sales by Country (2027-2032) & (K Units) Table 150. Middle East and Africa Praziquantel Revenue by Country (2021-2026) & (US$ Million) Table 151. Middle East and Africa Praziquantel Revenue by Country (2027-2032) & (US$ Million) Table 152. Global Praziquantel Sales by Type (2021-2026) & (K Units) Table 153. Global Praziquantel Sales by Type (2027-2032) & (K Units) Table 154. Global Praziquantel Sales Market Share by Type (2021-2026) Table 155. Global Praziquantel Sales Market Share by Type (2027-2032) Table 156. Global Praziquantel Revenue by Type (2021-2026) & (US$ Million) Table 157. Global Praziquantel Revenue by Type (2027-2032) & (US$ Million) Table 158. Global Praziquantel Revenue Market Share by Type (2021-2026) Table 159. Global Praziquantel Revenue Market Share by Type (2027-2032) Table 160. Global Praziquantel Price by Type (2021-2026) & (US$/Unit) Table 161. Global Praziquantel Price by Type (2027-2032) & (US$/Unit) Table 162. Global Praziquantel Sales by Application (2021-2026) & (K Units) Table 163. Global Praziquantel Sales by Application (2027-2032) & (K Units) Table 164. Global Praziquantel Sales Market Share by Application (2021-2026) Table 165. Global Praziquantel Sales Market Share by Application (2027-2032) Table 166. Global Praziquantel Revenue by Application (2021-2026) & (US$ Million) Table 167. Global Praziquantel Revenue by Application (2027-2032) & (US$ Million) Table 168. Global Praziquantel Revenue Market Share by Application (2021-2026) Table 169. Global Praziquantel Revenue Market Share by Application (2027-2032) Table 170. Global Praziquantel Price by Application (2021-2026) & (US$/Unit) Table 171. Global Praziquantel Price by Application (2027-2032) & (US$/Unit) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Praziquantel Distributors List Table 175. Praziquantel Customers List Table 176. Praziquantel Industry Trends Table 177. Praziquantel Industry Drivers Table 178. Praziquantel Industry Restraints Table 179. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Praziquantel Product Image Figure 5. Global Praziquantel Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Praziquantel Market Size (2021-2032) & (US$ Million) Figure 7. Global Praziquantel Sales (2021-2032) & (K Units) Figure 8. Global Praziquantel Average Price (US$/Unit) & (2021-2032) Figure 9. Patent Product Image Figure 10. Generic Product Image Figure 11. Liver Fluke Infection Product Image Figure 12. Cysticercosis Product Image Figure 13. Cestode Infections Product Image Figure 14. Trematode Infections Product Image Figure 15. Schistosoma Infection Product Image Figure 16. Others Product Image Figure 17. Global Praziquantel Revenue Share by Manufacturers in 2025 Figure 18. Global Manufacturers of Praziquantel, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Praziquantel Players Market Share by Revenue in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Praziquantel Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 22. Global Praziquantel Sales by Region in 2025 Figure 23. Global Praziquantel Revenue by Region in 2025 Figure 24. North America Praziquantel Market Size by Country in 2025 Figure 25. North America Praziquantel Sales Market Share by Country (2021-2032) Figure 26. North America Praziquantel Revenue Market Share by Country (2021-2032) Figure 27. United States Praziquantel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Canada Praziquantel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Praziquantel Market Size by Country in 2025 Figure 30. Europe Praziquantel Sales Market Share by Country (2021-2032) Figure 31. Europe Praziquantel Revenue Market Share by Country (2021-2032) Figure 32. Germany Praziquantel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Praziquantel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Praziquantel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Praziquantel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Praziquantel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Asia Pacific Praziquantel Market Size by Country in 2025 Figure 38. Asia Pacific Praziquantel Sales Market Share by Country (2021-2032) Figure 39. Asia Pacific Praziquantel Revenue Market Share by Country (2021-2032) Figure 40. China Praziquantel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Japan Praziquantel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. South Korea Praziquantel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. India Praziquantel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Australia Praziquantel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. China Taiwan Praziquantel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Southeast Asia Praziquantel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Southeast Asia Praziquantel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. South America Praziquantel Market Size by Country in 2025 Figure 49. South America Praziquantel Sales Market Share by Country (2021-2032) Figure 50. South America Praziquantel Revenue Market Share by Country (2021-2032) Figure 51. Mexico Praziquantel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Brazil Praziquantel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Argentina Praziquantel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Colombia Praziquantel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Middle East and Africa Praziquantel Market Size by Country in 2025 Figure 56. Middle East and Africa Praziquantel Sales Market Share by Country (2021-2032) Figure 57. Middle East and Africa Praziquantel Revenue Market Share by Country (2021-2032) Figure 58. Turkey Praziquantel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Praziquantel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. UAE Praziquantel Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Global Praziquantel Sales Market Share by Type (2021-2032) Figure 62. Global Praziquantel Revenue Market Share by Type (2021-2032) Figure 63. Global Praziquantel Price (US$/Unit) by Type (2021-2032) Figure 64. Global Praziquantel Sales Market Share by Application (2021-2032) Figure 65. Global Praziquantel Revenue Market Share by Application (2021-2032) Figure 66. Global Praziquantel Price (US$/Unit) by Application (2021-2032) Figure 67. Praziquantel Value Chain Figure 68. Praziquantel Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Praziquantel Industry Opportunities and Challenges

Scope & coverage.

Types
  • Patent
  • Generic
Applications
  • Liver Fluke Infection
  • Cysticercosis
  • Cestode Infections
  • Trematode Infections
  • Schistosoma Infection
  • Others
Companies covered
  • Zoetis
  • Merck
  • Bayer
  • Soparfin
  • Shin Poong Pharm
  • Richter Pharma
  • Norbrook Laboratories
  • Merial
  • Mavlab Animal Health
  • Lavet Pharmaceuticals
  • Kyron Pharma
  • Krka
  • Ecuphar
  • Covetrus
  • CiplaVet
  • Chanelle Pharma
  • Ceva Santé Animale
  • C and H Generics
  • Auvex
  • AniMedica

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Praziquantel Market Size (2021-2032)
  4. 2.2.2 Global Praziquantel Sales (2021-2032)
  5. 2.2.3 Global Praziquantel Market Average Price (2021-2032)
  6. 2.3 Praziquantel by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Patent
  9. 2.3.3 Generic
  10. 2.4 Praziquantel by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Liver Fluke Infection
  13. 2.4.3 Cysticercosis
  14. 2.4.4 Cestode Infections
  15. 2.4.5 Trematode Infections
  16. 2.4.6 Schistosoma Infection
  17. 2.4.7 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Praziquantel Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Praziquantel Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Praziquantel Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Praziquantel Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Praziquantel Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Praziquantel, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Praziquantel, Product Type & Application
  8. 3.8 Global Manufacturers of Praziquantel, Established Date
  9. 3.9 Global Praziquantel Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Zoetis
  2. 4.1.1 Zoetis Company Information
  3. 4.1.2 Zoetis Business Overview
  4. 4.1.3 Zoetis Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Zoetis Praziquantel Product Portfolio
  6. 4.1.5 Zoetis Recent Developments
  7. 4.2 Merck
  8. 4.2.1 Merck Company Information
  9. 4.2.2 Merck Business Overview
  10. 4.2.3 Merck Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Merck Praziquantel Product Portfolio
  12. 4.2.5 Merck Recent Developments
  13. 4.3 Bayer
  14. 4.3.1 Bayer Company Information
  15. 4.3.2 Bayer Business Overview
  16. 4.3.3 Bayer Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Bayer Praziquantel Product Portfolio
  18. 4.3.5 Bayer Recent Developments
  19. 4.4 Soparfin
  20. 4.4.1 Soparfin Company Information
  21. 4.4.2 Soparfin Business Overview
  22. 4.4.3 Soparfin Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Soparfin Praziquantel Product Portfolio
  24. 4.4.5 Soparfin Recent Developments
  25. 4.5 Shin Poong Pharm
  26. 4.5.1 Shin Poong Pharm Company Information
  27. 4.5.2 Shin Poong Pharm Business Overview
  28. 4.5.3 Shin Poong Pharm Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Shin Poong Pharm Praziquantel Product Portfolio
  30. 4.5.5 Shin Poong Pharm Recent Developments
  31. 4.6 Richter Pharma
  32. 4.6.1 Richter Pharma Company Information
  33. 4.6.2 Richter Pharma Business Overview
  34. 4.6.3 Richter Pharma Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Richter Pharma Praziquantel Product Portfolio
  36. 4.6.5 Richter Pharma Recent Developments
  37. 4.7 Norbrook Laboratories
  38. 4.7.1 Norbrook Laboratories Company Information
  39. 4.7.2 Norbrook Laboratories Business Overview
  40. 4.7.3 Norbrook Laboratories Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Norbrook Laboratories Praziquantel Product Portfolio
  42. 4.7.5 Norbrook Laboratories Recent Developments
  43. 4.8 Merial
  44. 4.8.1 Merial Company Information
  45. 4.8.2 Merial Business Overview
  46. 4.8.3 Merial Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Merial Praziquantel Product Portfolio
  48. 4.8.5 Merial Recent Developments
  49. 4.9 Mavlab Animal Health
  50. 4.9.1 Mavlab Animal Health Company Information
  51. 4.9.2 Mavlab Animal Health Business Overview
  52. 4.9.3 Mavlab Animal Health Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Mavlab Animal Health Praziquantel Product Portfolio
  54. 4.9.5 Mavlab Animal Health Recent Developments
  55. 4.10 Lavet Pharmaceuticals
  56. 4.10.1 Lavet Pharmaceuticals Company Information
  57. 4.10.2 Lavet Pharmaceuticals Business Overview
  58. 4.10.3 Lavet Pharmaceuticals Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Lavet Pharmaceuticals Praziquantel Product Portfolio
  60. 4.10.5 Lavet Pharmaceuticals Recent Developments
  61. 4.11 Kyron Pharma
  62. 4.11.1 Kyron Pharma Company Information
  63. 4.11.2 Kyron Pharma Business Overview
  64. 4.11.3 Kyron Pharma Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Kyron Pharma Praziquantel Product Portfolio
  66. 4.11.5 Kyron Pharma Recent Developments
  67. 4.12 Krka
  68. 4.12.1 Krka Company Information
  69. 4.12.2 Krka Business Overview
  70. 4.12.3 Krka Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Krka Praziquantel Product Portfolio
  72. 4.12.5 Krka Recent Developments
  73. 4.13 Ecuphar
  74. 4.13.1 Ecuphar Company Information
  75. 4.13.2 Ecuphar Business Overview
  76. 4.13.3 Ecuphar Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Ecuphar Praziquantel Product Portfolio
  78. 4.13.5 Ecuphar Recent Developments
  79. 4.14 Covetrus
  80. 4.14.1 Covetrus Company Information
  81. 4.14.2 Covetrus Business Overview
  82. 4.14.3 Covetrus Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Covetrus Praziquantel Product Portfolio
  84. 4.14.5 Covetrus Recent Developments
  85. 4.15 CiplaVet
  86. 4.15.1 CiplaVet Company Information
  87. 4.15.2 CiplaVet Business Overview
  88. 4.15.3 CiplaVet Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 CiplaVet Praziquantel Product Portfolio
  90. 4.15.5 CiplaVet Recent Developments
  91. 4.16 Chanelle Pharma
  92. 4.16.1 Chanelle Pharma Company Information
  93. 4.16.2 Chanelle Pharma Business Overview
  94. 4.16.3 Chanelle Pharma Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Chanelle Pharma Praziquantel Product Portfolio
  96. 4.16.5 Chanelle Pharma Recent Developments
  97. 4.17 Ceva Santé Animale
  98. 4.17.1 Ceva Santé Animale Company Information
  99. 4.17.2 Ceva Santé Animale Business Overview
  100. 4.17.3 Ceva Santé Animale Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Ceva Santé Animale Praziquantel Product Portfolio
  102. 4.17.5 Ceva Santé Animale Recent Developments
  103. 4.18 C and H Generics
  104. 4.18.1 C and H Generics Company Information
  105. 4.18.2 C and H Generics Business Overview
  106. 4.18.3 C and H Generics Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 C and H Generics Praziquantel Product Portfolio
  108. 4.18.5 C and H Generics Recent Developments
  109. 4.19 Auvex
  110. 4.19.1 Auvex Company Information
  111. 4.19.2 Auvex Business Overview
  112. 4.19.3 Auvex Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Auvex Praziquantel Product Portfolio
  114. 4.19.5 Auvex Recent Developments
  115. 4.20 AniMedica
  116. 4.20.1 AniMedica Company Information
  117. 4.20.2 AniMedica Business Overview
  118. 4.20.3 AniMedica Praziquantel Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 AniMedica Praziquantel Product Portfolio
  120. 4.20.5 AniMedica Recent Developments
5 Global Praziquantel Market Scenario by Region
  1. 5.1 Global Praziquantel Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Praziquantel Sales by Region: 2021-2032
  3. 5.2.1 Global Praziquantel Sales by Region: 2021-2026
  4. 5.2.2 Global Praziquantel Sales by Region: 2027-2032
  5. 5.3 Global Praziquantel Revenue by Region: 2021-2032
  6. 5.3.1 Global Praziquantel Revenue by Region: 2021-2026
  7. 5.3.2 Global Praziquantel Revenue by Region: 2027-2032
  8. 5.4 North America Praziquantel Market Facts & Figures by Country
  9. 5.4.1 North America Praziquantel Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Praziquantel Sales by Country (2021-2032)
  11. 5.4.3 North America Praziquantel Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Praziquantel Market Facts & Figures by Country
  15. 5.5.1 Europe Praziquantel Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Praziquantel Sales by Country (2021-2032)
  17. 5.5.3 Europe Praziquantel Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Praziquantel Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Praziquantel Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Praziquantel Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Praziquantel Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Praziquantel Market Facts & Figures by Country
  35. 5.7.1 South America Praziquantel Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Praziquantel Sales by Country (2021-2032)
  37. 5.7.3 South America Praziquantel Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.7.7 Colombia
  42. 5.8 Middle East and Africa Praziquantel Market Facts & Figures by Country
  43. 5.8.1 Middle East and Africa Praziquantel Market Size by Country: 2021 VS 2025 VS 2032
  44. 5.8.2 Middle East and Africa Praziquantel Sales by Country (2021-2032)
  45. 5.8.3 Middle East and Africa Praziquantel Revenue by Country (2021-2032)
  46. 5.8.4 Turkey
  47. 5.8.5 Saudi Arabia
  48. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Praziquantel Sales by Type (2021-2032)
  2. 6.1.1 Global Praziquantel Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Praziquantel Sales Market Share by Type (2021-2032)
  4. 6.2 Global Praziquantel Revenue by Type (2021-2032)
  5. 6.2.1 Global Praziquantel Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Praziquantel Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Praziquantel Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Praziquantel Sales by Application (2021-2032)
  2. 7.1.1 Global Praziquantel Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Praziquantel Sales Market Share by Application (2021-2032)
  4. 7.2 Global Praziquantel Revenue by Application (2021-2032)
  5. 7.2.1 Global Praziquantel Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Praziquantel Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Praziquantel Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Praziquantel Value Chain Analysis
  2. 8.1.1 Praziquantel Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Praziquantel Production Mode & Process
  5. 8.2 Praziquantel Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Praziquantel Distributors
  8. 8.2.3 Praziquantel Customers
9 Global Praziquantel Analyzing Market Dynamics
  1. 9.1 Praziquantel Industry Trends
  2. 9.2 Praziquantel Industry Drivers
  3. 9.3 Praziquantel Industry Opportunities and Challenges
  4. 9.4 Praziquantel Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst